Class Five Nevada v. Dow Corning Corp. (In Re Dow Corning Corp.)Class Five Nevada v. Dow Corning Corp. (In Re Dow Corning Corp.)
OPINION
BOYCE F. MARTIN, JR., Chief Circuit Judge. Years after Dow Corning Corporation filed a petition for reorganization under Chapter 11 of the Bankruptcy Code, and following extensive and vigorous negotiations, the third proposed plan of reorganization for Dow was submitted to the bankruptcy court. The bankruptcy court confirmed the Amended Joint Plan of Reorganization for Dow and the district court affirmed the bankruptcy court‘s Confirmation Order. Certain claimants who voted against the Plan appealed. The first principal issue presented here is whether a bankruptcy court may enjoin a non-consenting creditor‘s claims against a non-debtor to facilitate a reorganization plan under Chapter 11 of the Bankruptcy Code. For the following reasons, we AFFIRM the district court‘s conclusion that, under certain circumstances, a bankruptcy court may enjoin a non-consenting creditor‘s claim against a non-debtor to facilitate a Chapter 11 plan of reorganization. However, the factual findings of the bankruptcy court do not demonstrate that such an injunction is appropriate in this case. Therefore, we REMAND to the district court. The second issue presented is whether the Plan‘s classification of foreign claimants complies with the Bankruptcy Code‘s classification requirements. For the following reasons we AFFIRM the bankruptcy court‘s determination regarding the Plan‘s classification.
I.
For nearly thirty years, Dow was the predominant producer of silicone gel breast implants, accounting for almost fifty percent of the entire market. In addition, Dow supplied silicone raw materials to other manufacturers of silicone gel breast implants.
In the 1980s, certain medical studies suggested that silicone gel may cause auto-immune tissue diseases such as lupus, Scleroderma and rheumatoid arthritis. In 1992, the Food and Drug Administration ordered that silicone gel implants be taken off the market and Dow ceased manufacturing and marketing its silicone implants. Soon thereafter, tens of thousands of implant recipients sued Dow and its two shareholders, the Dow Chemical Company and Corning, Incorporated, claiming to have been injured by auto-immune reactions to the silicone in their implants. Other manufacturers and suppliers of silicone gel implants were named as co-defendants with Dow and its shareholders.
The Judicial Panel on Multidistrict Litigation consolidated the breast implant litigation for administration of pre-trial matters. See In re Silicone Gel Breast Implants Prods. Liab. Litig., 793 F. Supp. 1098 (J.P.M.L. 1992). The consolidated litigation led to a proposed $4.225 billion global settlement, which the multidistrict litigation court approved in 1994. See Lindsey v. Dow Corning Corp. (In re Silicone Gel Breast Implant Prods. Liab. Litig.), No. CV 92-P-10000-S, Civ. A. No. CV94-P-11558-S, 1994 WL 578353, at *1 (N. D. Ala. Sept. 1, 1994). However, hundreds of thousands more women than anticipated filed claims with the global settlement fund and the settlement collapsed in 1995.
Later that year, Dow filed a petition for reorganization under Chapter 11 of the Bankruptcy Code. In order to reduce its exposure to claims, immediately after it filed for bankruptcy, Dow sought to transfer all of the breast implant
The trustee in bankruptcy appointed several committees to represent the differing interests of Dow‘s claimants during the development of Dow‘s plan of reorganization. The Tort Claimants’ Committee vigorously opposed Dow‘s first two proposed reorganization plans. Dow then entered into mediation with the committees, and on February 4, 1999, Dow and the Tort Claimants’ Committee submitted the Amended Joint Plan of Reorganization to the bankruptcy court. On November 30, the bankruptcy court confirmed the Plan. In the following weeks, it issued seven separate
Because the bankruptcy court‘s opinions and the district court‘s opinion provide a detailed examination of the Plan, we discuss only the portions of the Plan that bear upon our decision.
Under the Plan, a $2.35 billion fund is established for the payment of claims asserted by (1) personal injury claimants, (2) government health care payers, and (3) other creditors asserting claims related to silicone-implant products liability claims. The $2.35 billion fund is established with funds contributed by Dow‘s products liability insurers, Dow‘s shareholders and Dow‘s operating cash reserves. As a quid pro quo for making proceeds available for the $2.35 billion fund, section 8.3 of the Plan releases Dow‘s insurers and shareholders from all further liability on claims arising out of settled personal injury claims, and section 8.4 permanently enjoins any party holding a claim released against Dow from
Under the Plan, claimants who choose to settle are channeled to the Settlement Facility, a legal entity created by the Plan and authorized to negotiate payments out of funds set aside for that purpose. Claimants who choose to litigate are channeled to the Litigation Facility, a legal entity created by the Plan that is essentially substituted for Dow as a defendant in the claimant‘s lawsuit.
The Plan divides claims and interests into thirty-three classes and subclasses. Classes 6.1 and 6.2 are composed of foreign breast-implant claimants who are given the opportunity to either settle or litigate their claims. Settlement payments to foreign breast implant claimants are between 35% and 60% of the amounts to be paid to domestic breast-implant claimants.
Class 15 is composed of all “Government Payer Claimants,” namely, the United States and the governments of the Canadian provinces of Alberta and Manitoba. Class 15 voted against the Plan. The United States filed claims under the Medicare Secondary Payer Program,
Class 15 claims not resolved before the Plan‘s Confirmation Date are liquidated through the Litigation Facility. Canada Claimants recovering through either the Settlement Facility or the Litigation Facility are required to notify the claims administrator of any unresolved subrogation claims or liens held by the Canadian provinces. The claims administrator is under a duty to determine whether one of the
The United States‘s claims are not accorded similar protection. The Plan does not specifically permit the United States to interfere with payment to a claimant. Once a specific claimant has been paid, the United States‘s claims against Dow, and all other entities created by the Plan, are cut off for costs related to that claimant.
The bankruptcy court confirmed the Plan, but construed the non-debtor release and injunction provisions to apply only to consenting creditors. In re Dow Corning Corp., 244 B.R at 745. Although the bankruptcy court determined that it has authority under the Bankruptcy Code to enjoin a non-consenting creditor‘s claims against non-debtors, it decided, based on non-bankruptcy law, that such injunctions are inappropriate as applied to non-consenting creditors, and construed the Plan accordingly. Id. The district court affirmed the bankruptcy court‘s Confirmation Order but reversed the bankruptcy court‘s interpretation of the release and injunction provisions of the Plan. The district court interpreted the non-debtor release and injunction provisions of the Plan to apply to all creditors, consenting and non-consenting.
II.
In a bankruptcy proceeding, the bankruptcy court is the finder of fact. In re Caldwell, 851 F.2d 852, 857 (6th Cir. 1988). When a district court acts as an appellate court as it does in a bankruptcy proceeding, it reviews the bankruptcy
The first issue we are asked to decide is whether a bankruptcy court has the authority to enjoin a non-consenting creditor‘s claims against a non-debtor to facilitate a reorganization plan under Chapter 11 of the Bankruptcy Code. This is a question of first impression in this Circuit.
The Bankruptcy Code does not explicitly prohibit or authorize a bankruptcy court to enjoin a non-consenting creditor‘s claims against a non-debtor to facilitate a reorganization plan. In re Continental Airlines, 203 F.3d 203, 211 (3d Cir. 2000). However, bankruptcy courts, “as courts of equity, have broad authority to modify creditor-debtor relationships.” United States v. Energy Resources Co., 495 U.S. 545, 549 (1990). For example, section 105 (a) of the Bankruptcy Code grants a bankruptcy court the broad authority to issue “any order, process, or judgment that is necessary or appropriate to carry out the provisions of this title.”
Consistent with section 105(a)‘s broad grant of authority, the Code allows bankruptcy courts considerable discretion to approve plans of reorganization. Energy Resources Co., 495 U.S. at 549. Section 1123(b)(6) permits a reorganization plan to “include any. . . appropriate provision not inconsistent
Nevertheless, some courts have found that the Bankruptcy Code does not permit enjoining a non-consenting creditor‘s claims against a non-debtor. See In re Lowenschuss, 67 F.3d 1394, 1401 (9th Cir. 1995); In re Western Real Estate Fund, Inc., 922 F.2d 592, 600 (10th Cir. 1990). These courts primarily rely on section 524(e) of the Code, which provides that “the discharge of the debt of the debtor does not affect the liability of any other entity on, or the property of any other entity for, such debt.”
The bankruptcy court concluded that non-debtor releases were authorized by section 1123(b)(6), but were precluded by
The district court rejected this argument on the grounds that the releases were authorized by “sufficient statutory authority under the Bankruptcy Code.” In re Dow Corning Corp., 255 B.R. at 480. For the following reasons, we agree with the district court. In Grupo Mexicano, the Supreme Court distinguished its own holding from that in United States v. First National City Bank, 379 U.S. 378 (1965). 527 U.S. at 326. First National approved an injunction preventing a third-party bank from transferring any of a taxpayer‘s assets. 379 U.S at 379-380. The Grupo Mexicano Court distinguished that holding on the grounds that the First National case “involved not the Court‘s general equitable powers under the Judiciary Act of 1789, but its powers under
Because we determine that enjoining a non-consenting creditor‘s claim against a non-debtor is “not inconsistent” with the Code and that Grupo Mexicano does not preclude such an injunction, we turn to when such an injunction is an “appropriate provision” of a reorganization plan pursuant to section 1123(b)(6). Because such an injunction is a dramatic measure to be used cautiously, we follow those circuits that have held that enjoining a non-consenting creditor‘s claim is only appropriate in “unusual circumstances.” See In re Drexel Burnham Lambert Group, Inc., 960 F.2d 285, 293 (2nd Cir. 1992); In Re A.H. Robins Co., 880 F.2d at 702; MacArthur v. Johns-Manville, Corp., 837 F.2d 89, 93-94 (2nd Cir. 1988). In determining whether there are “unusual circumstances,” our sister circuits have considered a number of factors, which are summarized in our holding below. We hold that when the following seven factors are present, the bankruptcy court may enjoin a non-consenting creditor‘s claims against a non-debtor: (1) There is an identity of interests between the debtor and the third party, usually an indemnity relationship, such that a suit against the non-debtor is, in essence, a suit against the debtor or will deplete the assets of the estate;
For several reasons, the record produced by the bankruptcy court in this case does not support a finding of “unusual circumstances” such that we can endorse enjoining non-consenting creditors’ claims against a non-debtor. The bankruptcy court‘s findings of fact with regards to the “unusual circumstances” test were no more than conclusory statements that restated elements of the test in the form of factual conclusions. The bankruptcy court provided no explanation or discussion of the evidence underlying these findings. Moreover, the findings did not discuss the facts as they related specifically to the various released parties, but merely made sweeping statements as to all released parties collectively. Such factual determinations are not sufficiently specific and explained to support a finding of “unusual circumstances.” And, when “the bankruptcy court‘s factual findings are silent or ambiguous as to. . . outcome determinative factual question[s],. . . [we] must remand the case to the bankruptcy court for the necessary factual determination[s].” In re Caldwell, 851 F.2d at 857.
Second, the bankruptcy court did not make sufficiently particularized factual findings that the Settling Insurers, Corning, Incorporated, the Dow Chemical Company, and Dow‘s affiliates will make significant contributions to the reorganization pursuant to the Plan. The bankruptcy court declared the contributions important without explaining how or why it reached this conclusion. To satisfy the “unusual circumstances” test, the bankruptcy court must specify facts that support a conclusion that the released parties will make significant contributions to the reorganization pursuant to the Plan.
Third, in order for the Plan to be approved under the “unusual circumstances” test, it must ensure an opportunity for those claimants who choose not to settle to recover in full, and this determination must be supported by particularized factual findings. The bankruptcy court determined that Class 15 claimants, composed of the United States and the Canadian provinces of Alberta and Manitoba, “who obtain judgments against the Litigation Facility will be paid in full.”
As an independent matter, the bankruptcy court had to determine whether Class 15 claimants were paid in full because the “cram down” provision of the Code required such a finding.
In addition, section 1123(a)(4) requires that claims of creditors that are members of the same class be treated equally.
The Canadian governmental payers are adequately protected under the Plan. They are protected because the Plan
In contrast, no such protections are provided to the United States. The Plan provides no practical mechanism by which the United States can prevent payment to a beneficiary. To the contrary, the Plan expressly states that the United States has no right to stop, delay, or interfere with payment to a beneficiary. Plan § 1.131; Settlement Facility Agreement § 7.02 (f). Furthermore, once a specific claimant has been paid, the United States‘s claims against Dow, and all other entities created by the Plan, are cut off for costs related to that claimant. Litigation Facility Agreement § 6.07 (a); Plan § 6.8. Moreover, the Plan fails to specify the amount of notice that the United States must receive before payment is made to a health care beneficiary.
Despite the Plan‘s lack of any adequate procedural protections for the United States, the bankruptcy court and
In order to ensure full payment the Plan must delineate procedural mechanisms for protecting the United States‘s claims. The full payment requirement of the “unusual circumstances” test and the Code‘s “cram down” provision would be met if the revised Plan (1) provides an adequate mechanism by which the United States can prevent the claims administrator from paying contested claims, such as providing the United States with the same kind of automatic suspension of payment to government beneficiaries that is afforded to the Canadian governmental payers under the British Columbia Class Action Settlement Agreement, and (2) specifies the amount and form of notice that must be given to the United
III.
The next issue we are asked to decide is whether the Plan‘s classification of foreign claimants meets the Bankruptcy Code‘s classification requirements. For the following reasons we hold that the Plan‘s classification of foreign claimants meets the Code‘s requirements.
Under the Plan, a foreign claimant is defined as someone who (1) is not a United States citizen, (2) is not a resident alien, or (3) did not have his or her medical procedure performed in the United States. Plan § 1.67. The Plan creates two classes for foreign claimants. Class 6.1 consists of claimants who are from a country that either (1) belongs to the European Union, (2) has a common law tort system, or (3) has a per capita Gross Domestic Product of greater than 60% of the United States‘s per capita Gross Domestic Product. Class 6.2 consists of claimants from all other countries. Class 5 generally consists of domestic breast-implant claimants. Class 6.1 claimants receive settlement offers of 60% of analogous domestic claimants’ settlements, and Class 6.2 receive settlements of 35% of the domestic claimants’ settlements. Members of both classes retain the option to litigate against the Litigation Facility for the full value of the claim should they deem the settlement offer inadequate.
The various groups of foreign claimants argue that their claims are not worth less than those of the domestic tort claimants and, therefore, should not be classified separately from domestic claims. The issue is whether the Plan improperly classifies the foreign claimants separately from
The Bankruptcy Code provides that “a plan may place a claim or an interest in a particular class only if such claim or interest is substantially similar to the other claims or interests of such class.”
In this case, the bankruptcy court determined that the evidence supported the factual assumptions upon which the classifications are based, and that given those facts, the Plan‘s classifications are proper. For example, the bankruptcy court found the testimony of three widely recognized expert witnesses helpful. These three expert witnesses had served on the panel for developing the classification scheme used in Bowling v. Pfizer, Inc., (S.D. Ohio 1995). Pfizer‘s classification scheme was the model used to develop the scheme in this case. Id. These expert witnesses explained the Pfizer methodology and its relevance to the current case. They offered quantitative evidence demonstrating that the highest tort awards in various other countries were significantly lower than in the United States. For example, one expert witness testified that the highest non-pecuniary award in injury cases in Australia is approximately $230,000. The bankruptcy court found these witnesses credible, in contrast to the foreign claimants’ witnesses, who the court found to be “unhelpful.” In re Dow Corning Corp., 244 B.R.
Second, the various groups of foreign claimants contend that their claims are more valuable than claims originating from other countries in their respective classes. They argue that the various claims in their class are not “substantially similar” as required by section 1122(a). They further argue that by giving identical consideration to class members whose claims are of different value, they are not being treated the same as other members of their class in violation of the Code‘s requirement that claimants within a class be treated equally.
The bankruptcy court relied on the testimony of a leading expert in comparative law methodology, Basil Markenisis, who pointed to legal, economic, and cultural factors supporting the bankruptcy court‘s conclusion that the claims within each class are “substantially similar.” Markenisis discussed (1) the availability of social safety nets in other countries, (2) other countries’ reliance on judges as opposed to juries, (3) limitations on punitive damages, (4) unavailability of contingency fees, (5) limitations on strict liability doctrines, (6) cultural factors, (7) reluctance to use
IV.
For the reasons set forth above, we AFFIRM the bankruptcy court‘s determination that the Plan‘s classification of foreign claimants meets the Bankruptcy Code‘s requirements. In addition, we AFFIRM the district court‘s determination that, when there are “unusual circumstances,” the bankruptcy court may enjoin non-consenting creditors’ claims against a non-debtor to facilitate a Chapter 11 plan of reorganization. However, we REMAND this case to the district court for those matters needing additional findings.